STRS Ohio’s RxSight RXST Stock Holding History

STRS Ohio’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,900	Closed	-$687K	–	2028
2024 Q3	$687K	Hold	13,900	–	–	﹤0.01%	1065
2024 Q2	$836K	Buy	+13,900	New	+$794K	﹤0.01%	943
2022 Q2	–	Sell	-1,900	Closed	-$23K	–	2258
2022 Q1	$23K	Hold	1,900	–	–	﹤0.01%	2032
2021 Q4	$21K	Hold	1,900	–	–	﹤0.01%	2112
2021 Q3	$24K	Buy	+1,900	New	+$26.2K	﹤0.01%	2169

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

STRS Ohio's RXST Position: Q4 2024 in Review

STRS Ohio sold out of RxSight (RXST) in Q4 2024, closing a stake of 13,900 shares — an estimated $687K sold.

STRS Ohio first reported a position in RXST in Q3 2021 and held it in 5 quarters. The position peaked at $836K in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

STRS Ohio reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
STRS Ohio sold 13,900 RxSight shares in Q4 2024, an estimated $687K.
STRS Ohio first reported a position in RxSight in Q3 2021 and held it in 5 quarters.
STRS Ohio's RxSight position peaked at $836K in Q2 2024.
212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on STRS Ohio's 13F filing for Q4 2024, filed 28 May 2025.